Promontory’s prostate cancer trial reaches patient enrolment milestone

Promontory’s prostate cancer trial reaches patient enrolment milestone

Submitted by admin on March 11, 2024 - 11:41am
Source: 
Clinical Trials Arena
News Tags: 
Promontory Therapeutics
clinical trials
PT-112
metastatic castration-resistant prostate cancer
prostate cancer
Headline: 
Promontory’s prostate cancer trial reaches patient enrolment milestone
snippet: 

Promontory Therapeutics has announced the completion of subject enrolment for its Phase II clinical trial of PT-112, a lead therapeutic candidate for metastatic castration-resistant prostate cancer (mCRPC).

Do Not Allow Advertisers to Use My Personal information